Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph phase_2
3
75%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Not yet recruiting3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 11 (25.0%)
Phase 23 (75.0%)

Trials by Status

not_yet_recruiting375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingphase_2

QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa

NCT07417917
not_yet_recruitingphase_2

QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis

NCT07377773
not_yet_recruitingphase_2

A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis

NCT07344051
recruitingphase_1

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

NCT06946641

Clinical Trials (4)

Showing 4 of 4 trials
NCT07417917Phase 2

QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa

Not Yet Recruiting
NCT07377773Phase 2

QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis

Not Yet Recruiting
NCT07344051Phase 2

A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis

Not Yet Recruiting
NCT06946641Phase 1

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4